Serious Long-Term Effects of Head and Neck Cancer from the Survivors’ Point of View
暂无分享,去创建一个
K. Bjordal | I. V. Verdonck‐de Leeuw | F. Jansen | E. Hammerlid | S. Singer | F. Tramacere | A. Boehm | S. Nuyts | M. Pinto | F. Duprez | B. Herlofson | N. Kiyota | A. Paderno | T. Dragan | R. R. Gama | C. Stromberger | G. Fanetti | C. Amdal | A. Fabian | M. Krüger | M. Plath | J. Inhestern | A. Jacinto | Ayman Bushnak | M. Scricciolo | Orlando Guntinas-Lichius | M. Kouri | P. Perotti | G. L. Astrup | J. C. Silva | Katherine J. Taylor | U. Wöhner | Pierluigi Bonomo | Noa Stempler | O. Guntinas-Lichius | Melissa Scricciolo
[1] I. V. Verdonck‐de Leeuw,et al. European Head and Neck Society recommendations for head and neck cancer survivorship care. , 2022, Oral oncology.
[2] N. Aaronson,et al. Correction to: Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire , 2022, Journal of Cancer Survivorship.
[3] J. Reijneveld,et al. Phase III study of the European Organisation for Research and Treatment of Cancer Quality of Life cancer survivorship core questionnaire , 2022, Journal of Cancer Survivorship.
[4] Matthew C. Miller,et al. Head and neck cancer survivorship consensus statement from the American Head and Neck Society , 2021, Laryngoscope investigative otolaryngology.
[5] A. Garden,et al. Determinants of patient‐reported xerostomia among long‐term oropharyngeal cancer survivors , 2021, Cancer.
[6] M. Halpern,et al. Impact of Pain on Employment and Financial Outcomes Among Cancer Survivors , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] N. Yarom,et al. Methodological approach for determining the Minimal Important Difference and Minimal Important Change scores for the European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module (EORTC QLQ-HN43) exemplified by the Swallowing scale , 2021, Quality of Life Research.
[8] J. Ferlay,et al. Cancer statistics for the year 2020: An overview , 2021, International journal of cancer.
[9] H. Kehlet,et al. Long‐term quality of life & functional outcomes after treatment of oropharyngeal cancer , 2020, Cancer medicine.
[10] J. Roick,et al. Predictors of changes in quality of life in head and neck cancer patients: a prospective study over a 6-month period , 2019, European Archives of Oto-Rhino-Laryngology.
[11] A. Dietz,et al. Quality of life during the first year after partial laryngectomy: Longitudinal study , 2018, Head & neck.
[12] C. von Buchwald,et al. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients. , 2017, European journal of cancer.
[13] S. Börjeson,et al. Health-related quality of life up to 1 year after radiotherapy in patients with head and neck cancer (HNC) , 2016, SpringerPlus.
[14] L. van der Molen,et al. Evaluation of long term (10-years+) dysphagia and trismus in patients treated with concurrent chemo-radiotherapy for advanced head and neck cancer. , 2015, Oral oncology.
[15] S. Tribius,et al. Residual deficits in quality of life one year after intensity-modulated radiotherapy for patients with locally advanced head and neck cancer , 2015, Strahlentherapie und Onkologie.
[16] H. Danker,et al. Quality of life before and after total laryngectomy: Results of a multicenter prospective cohort study , 2014, Head & neck.
[17] H. Brenner,et al. Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. , 2010, The oncologist.
[18] K. Bjordal,et al. Health‐related quality of life in patients with pharyngeal carcinoma: A five‐year follow‐up , 2006, Head & neck.
[19] K. Bjordal,et al. Quality of Life and Head and Neck Cancer: A 5 Year Prospective Study , 2005, The Laryngoscope.
[20] K. Bjordal,et al. P004: Health-Related Quality of Life Five Years after Diagnosis of Laryngeal Carcinoma , 2003, International journal of radiation oncology, biology, physics.
[21] P. Marcy,et al. Concomitant twice‐a‐day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long‐term quality of life analysis , 2001, Head & neck.
[22] P. Fayers,et al. A 12 country field study of the EORTC QLQ-C30 (version 3.0) and the head and neck cancer specific module (EORTC QLQ-H&N35) in head and neck patients. EORTC Quality of Life Group. , 2000, European journal of cancer.
[23] D. Osoba,et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. , 1993, Journal of the National Cancer Institute.